Lexaria Bioscience CORP. (LEXX) — S-1 Filings

All S-1 filings from Lexaria Bioscience CORP.. Browse 3 IPO Filing reports with AI-powered summaries and risk analysis.

S-1 Filings (3)

Lexaria Files S-1 for Resale of 2.76M Shares; DehydraTECH Shows Promise — Oct 14, 2025 Risk: high
Lexaria Bioscience Corp. (LEXX) is filing an S-1 to register 2,760,000 shares of common stock for resale by selling stockholders, primarily from warrants issued
Lexaria Bioscience Files S-1 for Securities Offering — Jun 3, 2024 Risk: medium
Lexaria Bioscience Corp. filed an S-1 form on June 3, 2024, to register securities. The company, incorporated in Nevada, is in the pharmaceutical preparations s
Lexaria Bioscience Corp. Files Form S-1 for Public Offering — Mar 12, 2024 Risk: medium
Lexaria Bioscience Corp. (LEXX) filed a IPO Registration (S-1) with the SEC on March 12, 2024. Lexaria Bioscience Corp. filed a Form S-1 with the SEC on March 1

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX